Search
Fortrea Holdings Inc
FTREAdd to Watchlist
17.920USD
+0.340+1.93%
Market hours （ET）Quotes delayed by 15 min
1.70BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Fortrea Holdings Inc is 7.09, ranking 311 out of 387 in the Biotechnology & Medical Research industry. The average price target is 11.50, with a high of 15.00 and a low of 7.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
16.850
Target Price
-3.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Fortrea Holdings Inc
FTRE
11
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fortrea Holdings Inc's expected revenue for the next quarter?
Fortrea Holdings Inc's expected revenue is 649.56M.
What is Fortrea Holdings Inc's price target?
Analysts forecast that Fortrea Holdings Inc's price target is USD 11.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 7.00.
How have Fortrea Holdings IncFTRE's recent earnings per share performed?
The market expectation was USD -0.25, while Fortrea Holdings IncFTRE's earnings per share (EPS) for the previous quarter was USD -0.35. EPS for the next quarter is expected at USD 0.18.
What is the analyst rating for Fortrea Holdings Inc?
Based on the ratings of Fortrea Holdings Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.